ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Rheumatology Network Staff

Rheumatology Network Staff

Posts by Author

© Lightspring/Shutterstock.com

This is the only fully human anti-TNF-α infused therapy approved for psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.

© Mike Focus/Shutterstock.com

Rheumatology leaders prescribe legislative fixes for drug cost and access issues.

The first patient-led, patient-centered research registry for joint, bone, and inflammatory skin conditions enrolls 11,000 patients.

A majority of patients said they found it difficult to explain the “invisible” aspects to others.

This study was the first to use an objective measure to link severity of psoriasis and risk of death.

Hypertension goes up more than with celecoxib in patients who are at increased risk for cardiovascular disease.

This is the first FDA-approved fixed-dose combination treatment that addresses both overproduction and underexcretion of serum uric acid in a single pill.

The need to find an alternative to prolonged periods of steroid therapy was addressed.

Patients demonstrated improved disease response in 2 clinical trials.

The first subcutaneous self-injection treatment option for patients with SLE has received approval.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.